MARKET

AEON

AEON

Aeon Biopharma
AMEX
0.9459
+0.0569
+6.40%
After Hours: 0.9309 -0.015 -1.59% 17:06 04/15 EDT
OPEN
0.8700
PREV CLOSE
0.8890
HIGH
0.9459
LOW
0.8501
VOLUME
1.12M
TURNOVER
--
52 WEEK HIGH
1.450
52 WEEK LOW
0.3788
MARKET CAP
23.93M
P/E (TTM)
-0.2393
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AEON last week (0406-0410)?
Weekly Report · 2d ago
Weekly Report: what happened at AEON last week (0330-0403)?
Weekly Report · 04/06 10:08
Aeon receives additional notice related to NYSE American listing standards
TipRanks · 04/06 01:20
AEON Biopharma Receives Additional NYSE American Noncompliance Notice
TipRanks · 04/03 20:37
AEON Biopharma receives additional NYSE American non-compliance notice
Seeking Alpha · 04/03 20:10
*AEON Biopharma: Company Is Not in Compliance With an Additional Continued Listing Standard >AEON
Dow Jones · 04/03 20:08
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Barchart · 04/03 15:10
AEON Posts Net Loss In FY25; Plans To Request BPD Type 2b Meeting For ABP-450 In 2026; Stock Down
NASDAQ · 03/31 10:06
More
About AEON
AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection or ABP-450, for debilitating medical conditions, with an initial focus on the neuroscience market. ABP-450 is a 2-chain polypeptide, a heavy chain joined by a bond to a light chain. ABP-450 interferes with nerve impulses by inhibiting the release of acetylcholine into the neuromuscular junction, causing a flaccid paralysis of muscles. The active biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a complete molecular complex weight of 900 kDa. Its initial development programs for ABP-450 are directed at migraine, cervical dystonia, gastroparesis and post-traumatic stress disorder (PTSD). The Company has completed enrollment and dosing of patients for a Phase II double blind study of ABP-450 for the treatment of both chronic and episodic migraine.

Webull offers Aeon Biopharma Inc stock information, including AMEX: AEON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AEON stock methods without spending real money on the virtual paper trading platform.